RT Journal Article
T1 Impact of the COVID-19 Pandemic on the Diagnosis and Prognosis of Melanoma.
A1 Martinez-Lopez, Antonio
A1 Diaz-Calvillo, Pablo
A1 Cuenca-Barrales, Carlos
A1 Montero-Vilchez, Trinidad
A1 Sanchez-Diaz, Manuel
A1 Buendia-Eisman, Agustin
A1 Arias-Santiago, Salvador
K1 COVID-19
K1 SARS-CoV-2
K1 melanoma
K1 pandemic
AB Background: Early detection of melanoma is one of the main diagnostic goals of dermatologists worldwide, due to the increasing incidence of the disease in our environment. However, the irruption of the SARS-CoV-2 pandemic has posed a challenge to global healthcare, forcing systems to focus their resources on the fight against COVID-19. Methods: Retrospective cohort study. The exposed cohort were patients diagnosed with melanoma in the year after the general confinement in Spain (15 March 2020) and the unexposed cohort were patients with melanoma diagnosed in the previous year. Results: 130 patients were included. No differences were observed between demographic characteristics in both cohorts. The mean Breslow of melanoma before the onset of the pandemic was 1.08, increasing to 2.65 in the year after the onset of the pandemic (p
SN 2077-0383
YR 2022
FD 2022-07-19
LK http://hdl.handle.net/10668/21325
UL http://hdl.handle.net/10668/21325
LA en
DS RISalud
RD Apr 18, 2025